| P50 | author | Hong-Xia Ma | Q87735703 |
| P2093 | author name string | Clive Wasserfall | |
| | Sihong Song | |
| | Mark A Atkinson | |
| | Yuanqing Lu | |
| | Keith Lowe | |
| | Lonneke van der Meijden-Erkelens | |
| P2860 | cites work | Adeno-associated virus vector as a platform for gene therapy delivery | Q64040883 |
| | Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice | Q68123525 |
| | Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent | Q70327797 |
| | Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle | Q73254110 |
| | Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108 | Q79375363 |
| | Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? | Q79830050 |
| | Type 1 diabetes: focus on prevention | Q80402893 |
| | Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice | Q90468943 |
| | Alpha-1 Antitrypsin Therapy for Autoimmune Disorders | Q91363611 |
| | Alpha1-antitrypsin protects beta-cells from apoptosis | Q40158851 |
| | Alpha-1 Antitrypsin Gene Therapy Ameliorates Bone Loss in Ovariectomy-Induced Osteoporosis Mouse Model | Q40763831 |
| | The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity. | Q42234561 |
| | Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 |
| | Anti-inflammaging effects of human alpha-1 antitrypsin | Q42778200 |
| | Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis | Q42832630 |
| | Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease | Q42996820 |
| | Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors | Q43716886 |
| | Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice | Q44678756 |
| | Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice | Q44719693 |
| | Autoimmune diabetes and the circle of tolerance | Q44745115 |
| | Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury | Q44966048 |
| | Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector | Q45419136 |
| | Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors | Q45735547 |
| | Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice | Q45859046 |
| | CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice | Q45875988 |
| | NKG2D blockade prevents autoimmune diabetes in NOD mice | Q46294168 |
| | T-lymphocyte clone specific for pancreatic islet antigen | Q46335815 |
| | Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice. | Q46401098 |
| | Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin | Q28218698 |
| | Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats | Q33671373 |
| | Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice | Q33922982 |
| | Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice | Q33950195 |
| | The discovery of α1-antitrypsin and its role in health and disease | Q34025923 |
| | Gene- and cell-based therapeutics for type I diabetes mellitus | Q35122170 |
| | alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis | Q35607245 |
| | Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation | Q35673668 |
| | Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. | Q35790490 |
| | Pancreas transplantation. An immunohistologic and histopathologic examination of 100 grafts. | Q35856482 |
| | Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector | Q35872651 |
| | Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein | Q35943644 |
| | Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus | Q36032325 |
| | Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus | Q36242842 |
| | Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells | Q36352899 |
| | Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. | Q36353954 |
| | In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 |
| | CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. | Q36399104 |
| | Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector | Q36663364 |
| | Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors | Q36734619 |
| | alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice | Q36935759 |
| | Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. | Q37303247 |
| | Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors | Q37385999 |
| | Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector. | Q39502530 |
| | Adeno-associated virus as a vector for liver-directed gene therapy. | Q39583470 |
| | Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model | Q39587262 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P921 | main subject | type-1 diabetes | Q124407 |
| P577 | publication date | 2019-08-28 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | Regulated hAAT Expression from a Novel rAAV Vector and Its Application in the Prevention of Type 1 Diabetes | |
| P478 | volume | 8 | |